| Pharmaceutical active ingredients: |
| Meperidine |
| Available forms, composition and doses of Antiduol: |
| N / A |
| Antiduol medical category: |
| Human:Anaesthetics - local and generalAnalgesics (opioid) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AB02 - Pethidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Anticoagulant Citrate Phosphate Dextrose Solution | Citric Acid Anhydrous; Citric Acid Monohydrate; Glucose Anhydrous; Glucose Monohydrate; Sodium Citrate Anhydrous; Sodium Citrate Dihydrate; Sodium Phosphate Monobasic; Sodium Phosphate Monobasic Anhydrous; Water for Injection | Unidentified Pharmaceutical Company |
| Anticoagulant Citrate-Phosphate-Glucose Solution | Citric Acid Anhydrous; Citric Acid Monohydrate; Glucose Anhydrous; Glucose Monohydrate; Sodium Citrate; Sodium Phosphate Monobasic; Water for Injection | Unidentified Pharmaceutical Company |
| Anticoagulant Heparin Solution | Heparin Sodium; Sodium Chloride | Unidentified Pharmaceutical Company |
| Anticol | Disulfiram | Unidentified Pharmaceutical Company |
| Antideprin | Imipramine | Unidentified Pharmaceutical Company |
| Antidurol | Meperidine | Unidentified Pharmaceutical Company |
| Anti-Ethyl | Disulfiram | Unidentified Pharmaceutical Company |
| Antietil | Disulfiram | Unidentified Pharmaceutical Company |
| Antifen | Acetylcysteine | Unidentified Pharmaceutical Company |
| Antiflex | Orphenadrine Citrate | Unidentified Pharmaceutical Company |